The current financial score of Guardant Health Inc is 7.06. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 334.98M, representing a year-over-year increase of 44.33%, while its net profit experienced a year-over-year increase of 20.26%.
The current valuation score of Guardant Health Inc is 9.80. Its current P/E ratio is -51.57, which is -100.00% below the recent high of 0.00 and 0.00% above the recent low of -51.57.
The current earnings forecast score of Guardant Health Inc is 8.74. The average price target is 192.54, with a high of 225.00 and a low of 92.41.
The current price momentum score of Guardant Health Inc is 4.02. Currently, the stock price is trading between the resistance level at 185.10 and the support level at 160.10, making it suitable for range-bound swing trading.
The current institutional shareholding score of Guardant Health Inc is 10.00. The latest institutional shareholding proportion is 101.63%, representing a quarter-over-quarter increase of 4.26%. The largest institutional shareholder is Catherine Wood, holding a total of 506.42K shares, representing 0.49% of shares outstanding, with 5.21% increase in holdings.
The current risk assessment score of Guardant Health Inc is 5.92. The company's beta value is 1.60. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.